Stavroula Sofou
7PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 14, 2025
Low-dose temozolomide selectively increases glioblastoma's vascular permeability, tumor microenvironment penetration and the killing potential of systemic actinium-225 α-particle dendrimer-radioconjugates improving treatment efficacy.Rajiv Ranjit Nair, Aira Sarkar, Pooja Hariharan
|Apr 19, 2024
Combined, yet separate: cocktails of carriers (not drugs) for actinium-225 α-particle therapy of solid tumors expressing moderate-to-low levels of targetable markers.Rajiv Ranjit Nair, Aprameya Prasad, Omkar Bhatavdekar
|May 23, 2022
Two diverse carriers are better than one: A case study in α-particle therapy for prostate specific membrane antigen-expressing prostate cancers.Dominick Salerno, Alaina Howe, Omkar Bhatavdekar
|Jun 12, 2021
Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases.Aprameya Prasad, Rajiv Nair, Omkar Bhatavdekar
|May 26, 2021
Daptomycin-Induced Lipid Phases on Model Lipid Bilayers: Effect of Lipid Type and of Lipid Leaflet Order on Membrane Permeability.Alaina Howe, Stavroula Sofou
|Dec 12, 2019
Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.Sally Stras, Alaina Howe, Aprameya Prasad
Pageof 2
